Showing 1051-1060 of 1395 results for "".
- Remdesivir, the First Coronavirus Drug, Gets a Price Taghttps://modernod.com/news/remdesivir-the-first-coronavirus-drug-gets-a-price-tag/2477953/Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced on Monday, accordin
- Saunders Finds Life After Allergan on Board at Newly IPO’ed BridgeBiohttps://modernod.com/news/saunders-finds-life-after-allergan-on-board-at-newly-ipoed-bridgebio/2477933/Less than 2 months after Allergan was officially taken in by AbbVie, its last helmsman, Brent Saunders, has landed on the board of a young biotech that recently pulled off a large IPO, according to a FiercePharma
- Asymptomatic Spread of Coronavirus is ‘Very Rare,’ WHO Sayshttps://modernod.com/news/asymptomatic-spread-of-coronavirus-is-very-rare-who-says/2477878/Coronavirus patients without symptoms aren’t driving the spread of the virus, World Health Organization officials said Monday, casting doubt on concerns by some researchers that the disease could be difficult to contain due to asymptomatic infections, CNBC
- Gottlieb, Mostashari Propose National COVID-19 Surveillance Systemhttps://modernod.com/news/gottlieb-mostashari-propose-national-covid-19-surveillance-system/2477555/Five healthcare experts—including former top government healthcare officials Scott Gottlieb and Farzad Mostashari—have proposed a plan to build a national COVID-19 surveillance system, according to a FierceHealthcare
- New Hope for Patients With Vision Loss at SAVIR-Center for Vision Restorationhttps://modernod.com/news/new-hope-for-patients-with-vision-loss-at-savir-center-for-vision-restoration/2477031/Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and
- Sight Sciences Announces Launches of TearCare and the Enhanced OMNI Systemhttps://modernod.com/news/sight-sciences-announces-official-launches-of-tearcare-and-the-enhanced-next-generation-omni-system/2476517/Sight Sciences announced the official commercial launch of TearCare and the introduction of an aesthetically and ergonomically enhanced OMNI Surgical System, which was initially launched in February 2018. The rollout of the new devices will include product dem
- Hoya Launches 4-in-1 Multisert Preloaded Delivery System with Vivinex IOLhttps://modernod.com/news/hoya-launches-4-in-1-multisert-preloaded-delivery-system-with-vivinex-iol/2479847/Hoya Surgical Optics officially launched the new multiSert 4-in-1 preloaded delivery system with Vivinex IOL at the European Society of Cataract and Refractive Surgeons (ESCRS) in Vienna, Austria. “MultiSert is
- Staar Surgical Announces Leadership Changeshttps://modernod.com/news/staar-surgical-announces-leadership-changes/2482682/Staar Surgical announced that Stephen C. Farrell, current Lead Independent Director of the Staar Board of Directors, has been appointed President and CEO, effective February 26, 2025. He is replacing Tom Frinzi, current President and CEO, who will remain with the company in an advisory role
- iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaginghttps://modernod.com/news/ihealthscreen-awarded-us-patent-on-glaucoma-detection-based-on-ai-and-color-fundus-imaging/2482232/iHealthScreen was awarded a full US patent by USPTO on March 26, 2024 for the iPredict glaucoma detection model. The iPredict is designed to provide a fully automated detection report for glaucoma, which can be implemented in the primary care settings for screening and detecti
- NEI Explores Potential Impacts of Climate Change on Eye Healthhttps://modernod.com/news/nei-explores-potential-impacts-of-climate-change-on-eye-health/2481635/The National Eye Institute (NEI) convened a panel of experts on April 26, 2023, at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to discuss teye health care needs of the future, including the potential effects of a changing climate on eye health a